Garden Stage Ltd, a Hong Kong-based diversified financial services provider, posted revenues rising from $1.4 million in 2024 to over $7.2 million in 2026 while concurrently deepening net losses to nearly $14 million in fiscal 2026 [F1][S1]. Its licensed subsidiaries deliver integrated services spanning securities brokerage, asset management, advisory, underwriting, and placement under Hong Kong’s SFO regulatory framework [S1]. The company also initiated robotics production through recent acquisitions and a wholly foreign-owned enterprise in China, representing a strategic diversification with limited current contribution [S1][S16]. Despite strong regulatory capital adequacy and improved liquidity metrics, Garden Stage faces challenges balancing growth investments against sustained operating deficits amid competitive pressures and market-dependent revenue streams [S10][F1].